Applications Published 16 August 2001
Published: 17-May-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Protein for treatment or prevention of a gastrointestinal tract disorder
Societe des Produits Nestle 1123011*Method for hardening the surface of sausage meat using ultrasonic treatment
Kortschack, Fritz 1123014*Preparations for topical application of substances having anti-androgenic effect
Aventis Pharma Deutschland 1123082*Use of testosterone esters and/or testosterone for producing bucally applicable bio-adhesive systems with time-released active ingredients
Jenapharm 1123084*O/W emulsion comprising an hydroxylated oil
West Pharmaceutical Services Drug Delivery & Clinical Research Centre 1123085*Artifical androgen-specific cells and related methods
Albani, Salvatore 1123086* Oral pulsed dose drug delivery system
Shire Laboratories 1123087*Controlled release pharmaceutical formulations containing a CGMP PDE-5 inhibitor
Pfizer Research and Development 1123088*Tablet for crunching with masked taste and instant release of active priniciple and method for making same
Gattefosse 1123089*Method and compsn for modulating amyloidosis
University of British Columbia 1123090*Combination product comprising an E-type prostaglandin ligand and a COX-2 selective inhibitor and methods of use
Merck Frost Canada 1123091*Fumaric acid microtablets
Fumapharm 1123092*Ubiguinone-containing compsn suitable for promoting enhanced intramitochondrial transportation of ubiquinones and methods of using the same
Sigma-Tau Healthscience 1123093* Therapeutic compsns (II)
BTG International 1123094*Pharmaceutical formulations useful to treat inflammatory and immune disorders
Millennium Pharmaceuticals 1123095*Bioflavonoids as plasma high density lipoprotein level increasing agent
Korea Institute of Science and Technology 1123096*Pharmaceutical compsn containing discursin
Chong, Se Young 1123097*Method for treating hot flashes in humans
Borbrove, Arthur; Urman, Jeffrey 1123098* Novel indenoisoquinolines as anti-neoplastic agents
Purdue Research Foundation; The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services 1123099* Improving memory by the administration of delta 5-androstene-3 beta-ol-7,17-dione and 3-beta esters thereof
Humanetics 1123100*Fluticasone lotion having improved vasoconstrictor activity
Glaxo Group 1123101* Method of preventing acute lung injury
The Research Foundation of State University of New York 1123102* A process for producing an iron-dextran compound
Pharmacosmos Holding 1123103* Inherently antimicrobial quaternary amine hydrogel wound dressings
Ballard Medical Products 1123104*Compsns containing eugenol and polyphenols and use of such a compsn for wound healing
Ebert, Dieter 1123106*Process for removing impurities from natural product extracts
Hauser 1123107*Isolated peptides which bind to HLA-B35 molecules
Ludwig Institute for Cancer Research 1123108*Contulakin-G, analogues thereof and uses therefore
Cognetix; The University of Utah Research Foundation; Salk Institute 1123109*Compsns and methods for promoting tissue repair using heat shock proteins
Fordham 1123110*Modulation of gene expression by combination therapy
Methylgene 1123111*Ionic molecular conjugates of N-acylated derivatives of poly (2-amino-2-deoxy-D-glucose) and polypeptides
Societe de Conseils de Recherches et d'Applications Scientifiques 1123112*Ribozymes used as prodrugs
Intelligene 1123113*Virus-like particles for the induction of autoantibodies
The USt Government, represented by Dept of Health and Human Services 1123114*Treatment of trauma (ie graft rejection) with liposomes containing DNA encoding for CTLA41G or for anti CD40L
Opperbas Holding 1123115*Hyperpolarised noble gas extraction methods, masking methods and associated transport containers
Medi-physics 1123117*Systems and compounds for drug delivery to interstitial regions of the myocardium
Biocardia 1123129*
